¿Qué es Amjevita?

Amjevita (adalimumab-atto) es un biosimilar de Humira, aprobado por la FDA para el tratamiento de múltiples condiciones inflamatorias, incluyendo la artritis reumatoide, la artritis psoriásica y la enfermedad de Crohn. Funciona inhibiendo el factor de necrosis tumoral (TNF), una proteína involucrada en la inflamación sistémica, reduciendo así la inflamación y ralentizando la progresión de la enfermedad. Amjevita se administra mediante inyección subcutánea y está destinado a utilizarse bajo la supervisión de profesionales de la salud.

Side Effects

• Cough, fever, chills, runny or stuffy nose, sore throat, body aches
• Changes in vision
• Sores or white patches on your lips, mouth, or throat

Warnings

• Tell your doctor if you are pregnant or breastfeeding, or if you have liver disease, COPD, heart failure, diabetes, psoriasis, multiple sclerosis, optic neuritis, problems with your immune system, or a history of cancer or Guillain-Barré syndrome. Tell your doctor if you have any type of infection (including hepatitis B or tuberculosis) or an infection that keeps coming back.
• This medicine may cause the following problems: Increased risk for infectionIncreased risk of certain cancers, including lymphoma or leukemiaNew or worsening heart failure
• You will need to have a skin test for tuberculosis (TB) before you start this medicine. Tell your doctor if you or anyone in your home has ever had a positive TB skin test or been exposed to TB.
• This medicine may make you bleed, bruise, or get infections more easily. Take precautions to prevent illness and injury. Wash your hands often.
• Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.